Literature identifier | Study type | Test dosage | Effective dosage | Endocrine-mediated endpoints | Systems-level perturbations |
---|---|---|---|---|---|
PMID:30986439 | IVR | 0.00312 mg/kg/day | 0.00312 mg/kg/day | Increased liver weights in offspring | Developmental endocrine-mediated perturbations;Hepatic endocrine-mediated perturbations |
IVR | 0.00312 mg/kg/day | 0.00312 mg/kg/day | Increased weights of epididymis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.00312 mg/kg/day | 0.00312 mg/kg/day | Increased prostate weights in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.00312 mg/kg/day | 0.00312 mg/kg/day | Abnormal sperm morphology in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.00312 mg/kg/day | 0.00312 mg/kg/day | Elevated glucose levels in offspring | Developmental endocrine-mediated perturbations;Metabolic endocrine-mediated perturbations | |
IVR | 0.00312 mg/kg/day | 0.00312 mg/kg/day | Increased weights of seminal vesicles in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.00312 mg/kg/day | 0.00312 mg/kg/day | Increased Alkaline phosphatase (ALP) levels in offspring | Developmental endocrine-mediated perturbations;Hepatic endocrine-mediated perturbations | |
IVR | 0.00312 mg/kg/day | 0.00312 mg/kg/day | Reduced sperm counts in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.05 mg/kg/day | 0.05 mg/kg/day | Increased weights of seminal vesicles in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.05 mg/kg/day | 0.05 mg/kg/day | Increased weights of epididymis in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.05 mg/kg/day | 0.05 mg/kg/day | Increased prostate weights in offspring | Developmental endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations | |
IVR | 0.0015 mg/kg/day | 0.0015 mg/kg/day | Increased weights of seminal vesicles in offspring | Developmental | |
IVR | 0.0015 mg/kg/day | 0.0015 mg/kg/day | Increased weights of epididymis in offspring | ||
IVR | 0.0015 mg/kg/day | 0.0015 mg/kg/day | Abnormal sperm morphology in offspring | ||
IVR | 0.0015 mg/kg/day | 0.0015 mg/kg/day | Increased liver weights in offspring | ||
IVR | 0.0015 mg/kg/day | 0.0015 mg/kg/day | Increased prostate weights in offspring | ||
IVR | 0.0015 mg/kg/day | 0.0015 mg/kg/day | Elevated glucose levels in offspring | ||
IVR | 0.075 mg/kg/day | 0.075 mg/kg/day | Increased prostate weights in offspring | ||
IVR | 0.075 mg/kg/day | 0.075 mg/kg/day | Increased weights of epididymis in offspring | ||
IVR | 0.075 mg/kg/day | 0.075 mg/kg/day | Increased weights of seminal vesicles in offspring | ||
IVR | 0.00075 mg/kg/day | 0.00075 mg/kg/day | Increased prostate weights in offspring | ||
IVR | 0.00075 mg/kg/day | 0.00075 mg/kg/day | Abnormal sperm morphology in offspring | ||
IVR | 0.00075 mg/kg/day | 0.00075 mg/kg/day | Increased Alkaline phosphatase (ALP) levels in offspring | ||
IVR | 0.00075 mg/kg/day | 0.00075 mg/kg/day | Increased weights of epidid | ||
IVR | 0.00075 mg/kg/day | 0.00075 mg/kg/day | |||
IVR | 0.00075 mg/kg/day | 0.00075 mg/kg/day | |||
IVR | 0.00075 mg/kg/day | 0.00075 mg/kg/day | |||
IVR | 0.00625 mg/kg/day | 0.00625 mg/kg/day | |||
IVR | 0.00625 mg/kg/day | 0.00625 mg/kg/day | |||
IVR | 0.00625 mg/kg/day | 0.00625 mg/kg/day | |||
IVR | 0.00625 mg/kg/day | 0.00625 mg/kg/day | |||
IVR | 0.00625 mg/kg/day | 0.00625 mg/kg/day | |||
IVR | 0.00625 mg/kg/day | 0.00625 mg/kg/day | |||
IVR | 0.0125 mg/kg/day | 0.0125 mg/kg/day | |||
IVR | 0.0125 mg/kg/day | 0.0125 mg/kg/day | |||
IVR | 0.0125 mg/kg/day | 0.0125 mg/kg/day |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.